Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer
| Image |  |
|---|---|
| Description | scientific article published on 8 March 2017 |
| Author/s |
author: Fadi Braiteh Herbert Hurwitz Ira Gore Niall Tebbutt Jacek Jassem Eric Van Cutsem |
| Publication date | March 8, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |